Key questions to discuss include: Whether you meet NHS criteria for GLP-1 prescription (type 2 diabetes or obesity with complications) The evidenceor lack thereoffor GLP-1 use specifically in Hashimoto's management Potential interactions between GLP-1 medications and thyroid hormone replacement How GLP-1 therapy might affect your thyroid function monitoring schedule Alternative evidence-based approaches to managing metabolic symptoms in Hashimoto's The costs and practicalities of private prescription if NHS funding is not available Contraception requirements if you are of childbearing potential (GLP-1 medications should be avoided in pregnancy and breastfeeding) Your GP may recommend optimising your current thyroid management first , ensuring your levothyroxine dose is appropriate and that you are not over- or under-replaced
Suliman M, Buckley A, Al Tikriti A, Tan T, le Roux CW, Lessan N, Barakat M
This is the first trial to demonstrate a significant cardiovascular benefit of a dual GLP-1/GIP agonist in HFpEF
Nausea and diarrhea were the most common side effects which were transient and improved with time, with less than 5% of the patients in the treatment group discontinuing treatment from gastrointestinal side effects
If you have health issues or are taking medication, always consult your doctor before taking certain supplements
Lab a Chip 21, 435446
